MNsure's chief executive announced his resignation Monday, paving the way for a third leadership shakeup at the beleaguered agency in less than 2 years.
MNsure's chief executive announced his resignation Monday, paving the way for a third leadership shakeup at the beleaguered agency in less than 2 years.
Scott Leitz will step down later this month after just 18 months on the job to take a position at a Washington, DC-based health policy think tank. MNsure's board of directors accepted his resignation Monday and appointed one of his deputies to lead the agency in the interim.
The leadership shakeup comes as Minnesota lawmakers debate the exchange's future, with proposals ranging from abolishing its governing board and establishing MNsure as a full-blown state agency to dismantling MNsure entirely and shifting to the federally-run exchange. Any planning for a permanent replacement will wait until Republicans and Democrats hammer out a deal to solidify MNsure's future.
Read more StarTribune: http://strib.mn/1Id3GVB
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More